Literature DB >> 15501531

Mechanisms underlying enhanced contractile response to endothelin-1 in diabetic rat basilar artery.

Takayuki Matsumoto1, Shintaro Yoshiyama, Tsuneo Kobayashi, Katsuo Kamata.   

Abstract

We investigated the influence of streptozotocin-induced diabetes on the responsiveness of the rat basilar artery to endothelin-1 (ET-1) and nitric oxide (NO), which is known to counteract ET-1. In basilar arteries isolated from diabetic rats: (a) the ET-1-induced contraction was enhanced, (b) the contraction induced by N(G)-nitro-l-arginine [a nitric oxide synthase (NOS) inhibitor] was weaker, and (c) the levels of the mRNAs for ET(A)/ET(B) receptors and prepro-ET-1, but not for NOS, were significantly elevated (all versus age-matched controls). These data indicate that ET-1-induced vasoconstriction may be increased in the diabetic rat basilar artery, and that this hyper-reactivity to ET-1 may be due to an overproduction of ET-1, an up-regulation of ET(A)/ET(B) receptors, and a defect in the bioavailability of NO.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501531     DOI: 10.1016/j.peptides.2004.07.001

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  17 in total

1.  Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes.

Authors:  Weiguo Li; Aisha I Kelly-Cobbs; Erin M Mezzetti; Susan C Fagan; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2010-08       Impact factor: 2.273

2.  The effect of endothelin receptor A antagonism on basilar artery endothelium-dependent relaxation after ischemic stroke.

Authors:  Maha Coucha; Weiguo Li; Adviye Ergul
Journal:  Life Sci       Date:  2012-02-16       Impact factor: 5.037

3.  Peroxynitrite decomposition with FeTMPyP improves plasma-induced vascular dysfunction and infarction during mild but not severe hyperglycemic stroke.

Authors:  Sara Morales Palomares; Ira Gardner-Morse; Julie G Sweet; Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-29       Impact factor: 6.200

4.  Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors.

Authors:  Aisha I Kelly-Cobbs; Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Vera Portik-Dobos; Maribeth Johnson; Adviye Ergul
Journal:  J Pharmacol Exp Ther       Date:  2010-12-23       Impact factor: 4.030

5.  Maternal high-fat diet programs cerebrovascular remodeling in adult rat offspring.

Authors:  ChengCheng Lin; XiaoYun Wu; YuLei Zhou; Bei Shao; XiaoTing Niu; WanLi Zhang; YuanShao Lin
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-15       Impact factor: 6.200

6.  Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes.

Authors:  Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Neurol Res       Date:  2011-03       Impact factor: 2.448

7.  Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes.

Authors:  Mohammed Abdelsaid; Handong Ma; Maha Coucha; Adviye Ergul
Journal:  Life Sci       Date:  2014-01-13       Impact factor: 5.037

8.  Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

Authors:  Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-20       Impact factor: 3.619

9.  Endothelin-1 Overexpression Exaggerates Diabetes-Induced Endothelial Dysfunction by Altering Oxidative Stress.

Authors:  Noureddine Idris-Khodja; Sofiane Ouerd; Muhammad Oneeb Rehman Mian; Jordan Gornitsky; Tlili Barhoumi; Pierre Paradis; Ernesto L Schiffrin
Journal:  Am J Hypertens       Date:  2016-11-01       Impact factor: 2.689

10.  Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Mostafa M Elgebaly; Alex K Harris; Jim R Hutchinson; Erin M Mezzetti; Vera Portik-Dobos; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.